Oncodesign SA
7Patents
7Active
7Granted
44Portfolio score
Filing activity: Sep 28, 2012 → Feb 28, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9096609B2 | Macrocyclic LRRK2 kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9090630B2 | Macrocyclic FLT3 kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9370519B2 | Macrocyclic FLT3 kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9586975B2 | Macrocyclic salt-inducible kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10377772B2 | Macrocyclic LRRK2 kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10676486B2 | Macrocyclic RIP2 kinase inhibitors | Human Necessities | 0 | Active |
| US10716869B2 | Radiolabeled macrocyclic EGFR inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.